...
首页> 外文期刊>Stem cell reviews and Reports >Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-beta 1
【24h】

Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-beta 1

机译:马骨髓间充质干细胞在马软骨工程中的表征与应用。 在BMP-2和TGF-β1的生物材料中培养时透明软骨形成潜力的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Articular cartilage presents a poor capacity for self-repair. Its structure-function are frequently disrupted or damaged upon physical trauma or osteoarthritis in humans. Similar musculoskeletal disorders also affect horses and are the leading cause of poor performance or early retirement of sport- and racehorses. To develop a therapeutic solution for horses, we tested the autologous chondrocyte implantation technique developed on human bone marrow (BM) mesenchymal stem cells (MSCs) on horse BM-MSCs. This technique involves BM-MSC chondrogenesis using a combinatory approach based on the association of 3D-culture in collagen sponges, under hypoxia in the presence of chondrogenic factors (BMP-2 + TGF-beta(1)) and siRNA to knockdown collagen I and HtrA1. Horse BM-MSCs were characterized before being cultured in chondrogenic conditions to find the best combination to enhance, stabilize, the chondrocyte phenotype. Our results show a very high proliferation of MSCs and these cells satisfy the criteria defining stem cells (pluripotency-surface markers expression). The combination of BMP-2 + TGF-beta(1) strongly induces the chondrogenic differentiation of MSCs and prevents HtrA1 expression. siRNAs targeting Col1a1 and Htra1 were functionally validated. Ultimately, the combined use of specific culture conditions defined here with specific growth factors and a Col1a1 siRNAs (50 nM) association leads to the in vitro synthesis of a hyaline-type neocartilage whose chondrocytes present an optimal phenotypic index similar to that of healthy, differentiated chondrocytes. Our results lead the way to setting up pre-clinical trials in horses to better understand the reaction of neocartilage substitute and to carry out a proof-of-concept of this therapeutic strategy on a large animal model.
机译:关节软骨呈现出差的自我修复能力。它的结构 - 功能经常被破坏或在人类的物理创伤或骨关节炎上损坏。类似的肌肉骨骼疾病也会影响马匹,是运动和赛马的表现不佳或早期退休的主要原因。为了开发马匹治疗溶液,我们测试了在马BM-MSC上的人骨髓(BM)间充质干细胞(MSC)上开发的自体软骨细胞植入技术。该技术涉及使用基于胶原蛋白海绵3D培养协会的组合方法,在软骨发生因子(BMP-2 + TGF-β(1))和siRNA敲低抗敲低的胶原蛋白I和SiRNA下htra1。在培养性疾病之前表征马BM-MSCs,以找到最佳组合,以增强,稳定,软骨细胞表型。我们的结果表明MSCs的非常高的增殖,这些细胞满足定义干细胞的标准(多能表面 - 表面标志物表达)。 BMP-2 + TGF-β(1)的组合强烈诱导MSC的软骨形成分化并防止HTRA1表达。瞄准COL1A1和HTRA1的SIRNA在功能验证。最终,这里定义的特定培养条件的结合使用具有特异性生长因子和COL1A1 siRNA(50nm)结合导致透明式新生途径的体外合成,其软骨细胞具有与健康,分化相似的最佳表型指数chondrocytes。我们的成果带来了在马匹中建立临床前试验,以更好地了解Neocartilage替代品的反应,并在大型动物模型中进行这种治疗策略的验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号